|
2008 Journal Article Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutationWillems, Amber J., Dawson, Sarah -J., Samaratunga, Hema, De Luca, Alessandro, Antill, Yoland C., Hopper, John L. and Thorne, Heather J. (2008). Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. Clinical Cancer Research, 14 (10), 2953-2961. doi: 10.1158/1078-0432.CCR-07-5237 |
|
2008 Journal Article Kallikrein-related peptidase 4( KLK4)initiates intracellular signaling via protease-activated receptors(PARs):KLK4 and PAR-2 are co-expressed during prostate cancer progressionRamsay, Andrew J., Dong, Ying, Hunt, Melanie L., Linn, MayLa, Samaratunga, Hemamali, Clements, Judith A. and Hooper, John D. (2008). Kallikrein-related peptidase 4( KLK4)initiates intracellular signaling via protease-activated receptors(PARs):KLK4 and PAR-2 are co-expressed during prostate cancer progression. The Journal of Biological Chemistry, 283 (18), 12293-12304. doi: 10.1074/jbc.M709493200 |
|
2008 Journal Article A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locusMyers, Stephen A., Kaushal, Aneel, Dong, Ying, Lai, John, Tan, Olivia L., Bui, Loan T., Hunt, Melanie L., Digby, Matthew R., Samaratunga, Hemamali, Gardiner, Robert A., Clements, Judith A. and Hooper, John D. (2008). A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Prostate, 68 (4), 381-399. doi: 10.1002/pros.20685 |
|
2008 Journal Article Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic functionDong, Ying, Matigian, Nick, Harvey, Tracey J., Samaratunga, Hemamali, Hooper, John D. and Clements, Judith A. (2008). Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function. Biological Chemistry, 389 (2), 99-109. doi: 10.1515/BC.2008.013 |
|
2008 Journal Article Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancerKelly Anne Landers, Samaratunga, Hemamali, Linda Teng, Buck, M., Burger, Michelle J., Betty Scells, Lavin, Martin F. and Gardiner, Robert A. (2008). Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. British Journal of Cancer, 99 (3), 491-501. doi: 10.1038/sj.bjc.6604486 |
|
2008 Journal Article What is the molecular pathology of low-risk prostate cancer?Samaratunga, Hemamali and Epstein, Jonathan I. (2008). What is the molecular pathology of low-risk prostate cancer?. World Journal of Urology, 26 (5), 431-436. doi: 10.1007/s00345-008-0260-5 |
|
2008 Journal Article Cellular angiofibroma of the scrotumSamaratunga, Hemamali and Fitzpatrick, Peter (2008). Cellular angiofibroma of the scrotum. Pathology, 40 (3), 330-333. doi: 10.1080/00313020701716409 |
|
2007 Journal Article Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polypSamaratunga, Hemamali and Letizia, Bernadette (2007). Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp. Pathology, 39 (5), 476-481. doi: 10.1080/00313020701570004 |
|
2007 Journal Article Significance of minute focus of adenocarcinoma on prostate needle biopsySamaratunga, Hemamali, Yaxley, John, Kerr, Kris, McClymont, Kelly and Duffy, David (2007). Significance of minute focus of adenocarcinoma on prostate needle biopsy. Urology, 70 (2), 299-302. doi: 10.1016/j.urology.2007.03.068 |
|
2007 Journal Article A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006)De Marzo, A. M., Platz, E. A., Epstein, J., Ali, T., Billis, A., Chan, T. Y., Cheng, L., Datta, M., Egevad, L., Ertoy-Baydar, D., Farre, X., Fine, S. W., Iczkowski, K. A., Ittmann, M., Knudsen, B. S., Loda, M., Lopez-Beltran, A., Magi-Galluzzi, C., Mikuz, G., Montironi, R., Pikarsky, E., Pizov, G., Rubin, M. A., Samaratunga, H., Sebo, T., Sesterhenn, I. A., Shah, R. B., Signoretti, S., Simko, J. ... Lucia, M. S. (2007). A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006). American Journal of Surgical Pathology, 31 (4), 652-652. |
|
2006 Journal Article A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006)De Marzo, A. M., Platz, E. A., Epstein, J., Ali, T., Billis, A., Chan, T. Y., Cheng, L., Datta, M., Egevad, L., Ertoy-Baydar, D., Farree, X., Fine, S. W., Iczkowski, K. A., Ittmann, M., Knudsen, B. S., Loda, M., Lopez-Beltran, A., Magi-Galluzzi, C., Mikuz, G., Montironi, R., Pikarsky, E., Pizov, G., Rubin, M. A., Samaratunga, H., Sebo, T., Sesterhenn, I. A., Shah, R. B., Signoretti, S., Simko, J. ... Lucia, M. S. (2006). A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006). American Journal of Surgical Pathology, 30 (11), 1489-1489. |
|
2006 Journal Article Atypical prostatic glandular proliferations on needle biopsy - Diagnostic implications, use of immunohistochemistry, and clinical significanceSamaratunga, H., Gardiner, R.A., Yaxley, J. and Brown, I. (2006). Atypical prostatic glandular proliferations on needle biopsy - Diagnostic implications, use of immunohistochemistry, and clinical significance. Analytical And Quantitative Cytology And Histology, 28 (2), 104-110. |
|
2006 Journal Article A working group classification of focal prostate atrophy lesionsDe Marzo A.M., Platz E.A., Epstein J.I., Ali T., Billis A., Chan T.Y., Cheng L., Datta M., Egevad L., Ertoy-Baydar D., Farree X., Fine S.W., Iczkowski K.A., Ittmann M., Knudsen B.S., Loda M., Lopez-Beltran A., Magi-Galluzzi C., Mikuz G., Montironi R., Pikarsky E., Pizov G., Rubin M.A., Samaratunga H., Sebo T., Sesterhenn I.A., Shah R.B., Signoretti S., Simko J. ... Lucia M.S. (2006). A working group classification of focal prostate atrophy lesions. American Journal of Surgical Pathology, 30 (10), 1281-1291. doi: 10.1097/01.pas.0000213289.50660.be |
|
2005 Journal Article Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted formsDong, Y., Bui, L. T., Odorico, D. M., Tan, O. L., Myers, S. A., Samaratunga, H., Gardiner, R. A. and Clements, J. A. (2005). Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Endocrine-Related Cancer, 12 (4), 875-889. doi: 10.1677/erc.1.01062 |
|
2005 Journal Article Significance of stromal reaction patterns in invasive urothelial carcinomaSamaratunga, H, Fairweather, P and Purdie, D (2005). Significance of stromal reaction patterns in invasive urothelial carcinoma. American Journal of Clinical Pathology, 123 (6), 851-857. doi: 10.1309/EE8RTB6X611G6TU |
|
2005 Journal Article Use of multiple biomarkers for a molecular diagnosis of prostate cancerLanders, Kelly A., Burger, Michelle J., Tebay, Michelle A., Purdie, David M., Scells, Betty, Samaratunga, Hemamali, Lavin, Martin F. and Gardiner, Robert A. (2005). Use of multiple biomarkers for a molecular diagnosis of prostate cancer. International Journal of Cancer, 114 (6), 950-956. doi: 10.1002/ijc.20760 |
|
2004 Journal Article Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical studySamaratunga, H and Khoo, K (2004). Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology, 45 (1), 55-64. doi: 10.1111/j.1365-2559.2004.01895.x |
|
2004 Journal Article Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaPMcCulloch, Daniel R, Akl, Pascal, Samaratunga, Hemamali, Herington, Adrian C. and Odorico, Dimitri M. (2004). Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clinical Cancer Research, 10 (1), 314-323. doi: 10.1158/1078-0432.CCR-0846-3 |
|
2002 Journal Article Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancerBurger, M. J., Tebay, M. A., Keith, P. A., Samaratunga, H. M., Clements, J. A., Lavin, M. F. and Gardiner, R. A. (2002). Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer. International Journal of Cancer, 100 (2), 228-237. doi: 10.1002/ijc.10468 |
|
2002 Journal Article Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progressionSamaratunga H., Makarov D.V. and Epstein J.I. (2002). Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology, 60 (2), 315-319. doi: 10.1016/S0090-4295(02)01705-3 |
